
Looking for biotech stocks with upside that could help people fight illness? Here are three that analysts think might be worth a look.
High-signal headlines only - macro events, earnings, M&A, regulatory. Listicles and analyst clickbait filtered out by default. Refreshed hourly.

Looking for biotech stocks with upside that could help people fight illness? Here are three that analysts think might be worth a look.

Edesa Biotech, Inc. (NASDAQ:EDSA) shares fell nearly 13% in Thursday premarket trading after the company priced a $25 million public stock offering. Edesa Biotech shares fell 18.27% to $4.70 in Wednesday’s after-market session, putting the stock on traders’ radars. The move followed the company’s Q3 earnings release, which came out four days earlier, according to Benzinga’s after-hours movers recap. What Is Edesa Biotech’s Financing Deal? Edesa is raising fresh capital via an equity offering of
Healthcare stocks rose Friday afternoon, with the NYSE Healthcare Index increasing 1.2% and the Stat
Insiders who bought Edesa Biotech, Inc. ( NASDAQ:EDSA ) stock in the last 12 months were richly rewarded last week. The...
Edesa Biotech Inc. (NASDAQ:EDSA) is one of the 10 Unstoppable Stocks That Could Double Your Money. Edesa Biotech Inc. (NASDAQ:EDSA) is one of the unstoppable stocks that could double your money. On March 26, Edesa reaffirmed that enrollment for its Phase 2 clinical study of EB06, which is a treatment for moderate-to-severe nonsegmental vitiligo, is […]
Elong Power Holding Ltd. 49,425,228 0.49
Usually, when one insider buys stock, it might not be a monumental event. But when multiple insiders are buying like...
Generally, when a single insider buys stock, it is usually not a big deal. However, when several insiders are buying...
We use Google Analytics to count anonymous page views and understand which content gets read. No ads, no profiles. Decline keeps you on cookieless mode. Details.